Private Equity
Boston-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has secured $29.5 million in Series B financing. Perceptive Advisors led the round with participation from other investors that included RA Capital Management, ArrowMark Partners, Soleus Capital, Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.
1 min read · 26 September 2018
Capella Space said it raised $19 million of Series B capital in a round led by Spark Capital and Data Collective.
4 min read · 26 September 2018
Minoryx Therapeutics said Sept. 26 that it raised 21.3 million euros ($25 million) in a Series B round led by Fund+. Also participating were SFPI, S.R.I.W. and Sambrinvest, in addition to all Series A investors (Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital Risc and HealthEquity). Minoryx is developing drugs for orphan disease.
6 min read · 26 September 2018
Berkeley, California-based Bleximo Corp, which focuses on quantum computing applications, announced it has raised $1.5 million in seed-stage funding led by Eniac Ventures. Also participating are Boost VC, Creative Ventures, KEC Ventures and Gyan Kapur. Bleximo was founded last year by Cyclotron Road fellow and quantum expert Alexei Marchenkov.
1 min read · 25 September 2018
Troy Capital Group and an Oaktree Capital Management affiliate said they created a $200 million fund to provide loan-based liquidity to employees and investors of pre-IPO private companies. Among Troy's co-founders is Josh Berman, co-founder of MySpace.
3 min read · 25 September 2018
Grubhub has agreed to acquire Israeli-based Tapingo, provider of an on-campus food ordering platform, for $150 million. The deal is expected to close in the fourth quarter. Tapingo, which also has an office in San Francisco, has raised about $36 million in venture funding from Khosla Ventures, Qualcomm Ventures, Viola Ventures and DCM Ventures, among others.
1 min read · 25 September 2018
Trait Biosciences Inc, a Vancouver-based cannabis biotechnology company, has closed a seed-stage financing of $12.3 million. The round was led by incoming Trait senior managers, Joseph del Moral, Hannan Fleiman and Ronan Levy, and joined by Green Acre Capital, CannaIncome Fund and industry executives. Trait is developing enhanced cannabinoids, including water-soluble cannabinoids. It is also is developing technologies to increase plant yields and safety. The funds raised will be used for research and patent creation, as well as the construction of a second laboratory in Toronto.
4 min read · 25 September 2018
Atlanta-based Kobiton, a mobile app testing company, has secured $3 million in seed funding. Kinetic Ventures led the round with participation from KMS Technology and Service Provider Capital.
3 min read · 25 September 2018
MindBeacon Group, the Toronto-based developer and operator of digital therapy platform Beacon, has closed a Series A financing, bringing its total funding to more than $20 million. The investors included Telus Ventures, Manulife, Elkland Capital and Strauss Interests. Beacon was introduced in 2016 in CBT Associates clinics. Last year, it was launched as a provider of digitally-delivered therapy for people with mental health concerns, such as depression, anxiety, panic and post-traumatic stress disorder. MindBeacon Chair and CEO Sam Duboc said the funds raised will help his company enhance its offerings and increase its reach in Canada.
3 min read · 25 September 2018
Fremont, California-based Cytek Biosciences Inc, a provider of flow cytometry solutions, has raised an undisclosed amount of Series C funding. Northern Light Venture Capital and 3E Bioventures led the round. In conjunction with the funding, Feng Deng, founder of Northern Lights Ventures, will join Cytek’s board of directors.
1 min read · 25 September 2018